Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Virological characteristics of the SARS-CoV-2 JN.1 variant

Y. Kaku, K. Okumura, M. Padilla-Blanco, Y. Kosugi, K. Uriu, AA. Hinay, L. Chen, A. Plianchaisuk, K. Kobiyama, KJ. Ishii, Genotype to Phenotype Japan (G2P-Japan) Consortium, J. Zahradnik, J. Ito, K. Sato

. 2024 ; 24 (2) : e82. [pub] 20240103

Jazyk angličtina Země Spojené státy americké

Typ dokumentu dopisy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007307
E-zdroje Online Plný text

NLK ProQuest Central od 2001-08-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2001-08-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2001-08-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2001-08-01 do Před 2 měsíci

Odkazy

PubMed 38184005
DOI 10.1016/s1473-3099(23)00813-7
Knihovny.cz E-zdroje

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007307
003      
CZ-PrNML
005      
20240423155851.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/S1473-3099(23)00813-7 $2 doi
035    __
$a (PubMed)38184005
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kaku, Yu $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
245    10
$a Virological characteristics of the SARS-CoV-2 JN.1 variant / $c Y. Kaku, K. Okumura, M. Padilla-Blanco, Y. Kosugi, K. Uriu, AA. Hinay, L. Chen, A. Plianchaisuk, K. Kobiyama, KJ. Ishii, Genotype to Phenotype Japan (G2P-Japan) Consortium, J. Zahradnik, J. Ito, K. Sato
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $7 D000086382
650    _2
$a SARS-CoV-2 $7 D000086402
655    _2
$a dopisy $7 D016422
700    1_
$a Okumura, Kaho $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Faculty of Liberal Arts, Sophia University, Tokyo, Japan
700    1_
$a Padilla-Blanco, Miguel $u First Medical Faculty at Biocev, Charles University, Prague, Czechia; Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain
700    1_
$a Kosugi, Yusuke $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Uriu, Keiya $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Hinay, Alfredo A $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Chen, Luo $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
700    1_
$a Plianchaisuk, Arnon $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Kobiyama, Kouji $u Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Ishii, Ken J $u Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Zahradnik, Jiri $u First Medical Faculty at Biocev, Charles University, Prague, Czechia
700    1_
$a Ito, Jumpei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan
700    1_
$a Sato, Kei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address: keisato@g.ecc.u-tokyo.ac.jp
710    2_
$a Genotype to Phenotype Japan (G2P-Japan) Consortium
773    0_
$w MED00006437 $t Lancet. Infectious diseases $x 1474-4457 $g Roč. 24, č. 2 (2024), s. e82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38184005 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155847 $b ABA008
999    __
$a ok $b bmc $g 2081346 $s 1217074
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 2 $d e82 $e 20240103 $i 1474-4457 $m Lancet. Infectious diseases $n Lancet Infect Dis $x MED00006437
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace